Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6130452 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL2815185 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL1012002 | 0.95 | — | — | |
| SCHEMBL7611223 | 0.89 | — | — | |
| Water SCHEMBL29044816 | 0.89 | — | — | |
| Water SCHEMBL27628794 | 0.89 | — | — | |
| Fluoride SCHEMBL4381469 | 0.89 | — | — | |
| SCHEMBL608384 | 0.89 | — | — | |
| Water SCHEMBL916471 | 0.89 | — | — | |
| Bromide SCHEMBL385047 | 0.89 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1294922-B1 | TREATING CANCER USING ORGANELLE CRYSTALLIZING AGENTS | KONG QINGZHONG (CN) | 2010-04-14 | — | — | EP | claimed |
| US-7524872-B2 | Method and composition for treating cancer using cellular organelle crystallizing agents | KONG QINGZHONG | 2009-04-28 | — | — | US | claimed |
| US-20060286170-A1 | Method and composition for treating cancer using cellular organelle crystallizing agents | KONG QINGZHONG | 2006-12-21 | — | — | US | claimed |
| US-7102011-B2 | Methods and compositions for the visualization of cellular organelles using tetrazolium salts | KONG QINGZHONG | 2006-09-05 | — | — | US | claimed |
| US-6864272-B2 | Method and composition for treating cancer using cellular organelle crystallizing agents | KONG QINGZHONG (US) | 2005-03-08 | — | — | US | claimed |
| EP-1294922-A2 | METHOD FOR TREATING CANCER, VISUALIZING CELL STRUCTURES, AND ISOLATING ORGANELLES USING ORGANELLE CRYSTALLIZING AGENTS | Kong, Qingzhong (US) | 2003-03-26 | — | — | EP | claimed |
| US-20020143042-A1 | Method and composition for treating cancer using cellular organelle crystallizing agents | KONG QINGZHONG (US) | 2002-10-03 | — | — | US | claimed |
| US-20020086345-A1 | Methods and compositions for the visualization of cellular organelles using tetrazolium salts | KONG QINGZHONG (US) | 2002-07-04 | — | — | US | claimed |
| US-6376525-B1 | Tetrazolium salts and derivatives, preferably tetrazolium red and tetrazolium violet, in combination with chemotherapeutic agents delivered in a polylactic acid carrier; noninvasive antitumor treatments | KONG QINGZHONG (US) | 2002-04-23 | — | — | US | claimed |
| US-6368818-B1 | VISUAL AIDS AND CANCER TREATMENT | KONG QINGZHONG (US) | 2002-04-09 | — | — | US | claimed |
| WO-2001082780-A2 | METHOD FOR TREATING CANCER, VISUALIZING CELL STRUCTURES, AND ISOLATING ORGANELLES USING ORGANELLE CRYSTALLIZING AGENTS | KONG QINGZHONG (US) | 2001-11-08 | — | — | WO | claimed |
| CN-114980887-A | Fluoroalkyl-oxadiazoles and their use | 特纳亚治疗股份有限公司 | 2022-08-30 | — | — | CN | disclosed |
| US-9034593-B2 | Vaginal indicator to detect biomarkers of good health | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2015-05-19 | — | — | US | disclosed |
| EP-2643473-A2 | VAGINAL INDICATOR TO DETECT BIOMARKERS OF GOOD HEALTH | Kimberly-Clark Worldwide, Inc. (US) | 2013-10-02 | — | — | EP | disclosed |
| WO-2012069941-A2 | VAGINAL INDICATOR TO DETECT BIOMARKERS OF GOOD HEALTH | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2012-05-31 | — | — | WO | disclosed |
| EP-0767909-A1 | MULTI-LAYER TEST DEVICES AND METHODS OF ASSAYING FOR FRUCTOSAMINE | LXN CORPORATION (US) | 1997-04-16 | — | — | EP | disclosed |
| WO-1996031270-A1 | WHOLE BLOOD SEPARATION METHOD AND DEVICES | LXN CORPORATION (US) | 1996-10-10 | — | — | WO | disclosed |
| WO-1996031619-A1 | COMBINED ASSAY FOR CURRENT GLUCOSE LEVEL AND INTERMEDIATE OR LONG-TERM GLYCEMIC CONTROL | LXN CORPORATION (US) | 1996-10-10 | — | — | WO | disclosed |
| WO-1996000897-A1 | MULTI-LAYER TEST DEVICES AND METHODS OF ASSAYING FOR FRUCTOSAMINE | LXN CORPORATION (US) | 1996-01-11 | — | — | WO | disclosed |
| US-5470752-A | Diabetes | LXN CORPORATION (US) | 1995-11-28 | — | — | US | disclosed |